Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk?

Robert W Snow1, Eline L Korenromp, Eleanor Gouws

  • 1Kenya Medical Research Institute-Wellcome Trust Collaborative Program, Nairobi, Kenya. rsnow@wtnairobi.mimcom.net

Insights

Malaria significantly increases all-cause mortality in African children under five. Current burden estimations may underestimate malaria

Area of Science:

  • Global Health Epidemiology
  • Infectious Disease Research
  • Pediatric Mortality Studies

Background:

  • The Disability Adjusted Life Year (DALY) approach is standard for global health burden assessment.
  • Malaria's impact, including chronic anemia and low birth weight, may be inadequately represented by DALYs.
  • Understanding malaria's role in all-cause mortality is crucial for effective child health interventions.

Purpose of the Study:

  • To assess malaria as a risk factor for all-cause mortality in African children under five.
  • To compare ecological associations with intervention trial data regarding malaria's mortality impact.

Main Methods:

  • Ecological analysis of Plasmodium falciparum infection prevalence (PR) and under-five mortality across 48 demographic surveillance studies.
  • Evaluation of reductions in all-cause under-five mortality from malaria intervention trials, specifically insecticide-treated mosquito nets.

Main Results:

  • Adjusted PR was associated with more than a doubling of all-cause under-five mortality (P = 0.0001).
  • Malaria intervention trials indicated smaller population-attributable fractions of pediatric mortality compared to ecological findings.
  • Discrepancies may stem from imperfect intervention coverage and efficacy in trials.

Conclusions:

  • Malaria's contribution to mortality in African children may exceed estimates derived from cause-specific DALYs.
  • A comprehensive understanding of malaria's multifaceted burden is essential for public health policy.
  • Further research is needed to refine burden estimation methodologies for infectious diseases.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...